| Literature DB >> 32571225 |
Maha K AlYousef1, Ahmed A Al-Sayed2,3, Ayham Al Afif4, Uthman Alamoudi4,5, Jaclyn M LeBlanc6, Robin LeBlanc4.
Abstract
BACKGROUND: Thyroid gland infections are rare. Their incidence is estimated to be less than 1% in immunocompromised hosts. Most common pathogens isolated are Gram positive aerobic cocci. Infections with Gram negative facultative aerobes such as Salmonella are rare. CASEEntities:
Keywords: Salmonella; Suppurative thyroiditis; Thyroid abscess; Thyroiditis
Year: 2020 PMID: 32571225 PMCID: PMC7310241 DOI: 10.1186/s12879-020-05161-w
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1An enhanced CT scan of the neck on initial presentation. a-c showing the axial views from superior to inferior, d-f showing the coronal views from anterior to posterior and f showing the sagittal view. Images are showing a large lobulated cystic lesion with some thin septations, measuring about 6.1 × 4.4 × 4.6 cm in maximal craniocaudal, anterior-posterior, and transverse dimensions, respectively
Fig. 2Ultrasound of the neck. Showing a large complex cystic lesion in the mid to lower portion of the right lobe. It measures about 4.9 cm × 2.3 cm × 4.8 cm
Fig. 3An enhanced CT scan of the neck after antibiotic therapy. a-c showing the axial views from superior to inferior, d-e showing the coronal views from anterior to posterior and f showing the sagittal view. The images show a loculated cystic lesion with internal septations in the mid lower lobe of the right thyroid which measures 3.7 × 4.3 × 5 cm in size. However, it has a progressively thickened heterogeneously enhancing wall. The white arrow on figure a pointing the right infrahyoid muscle that is slightly thickened with adjacent inflammatory stranding
List of published cases of AST due to Salmonella spp.
| Case Number | Publication | Number of Cases | Age& Gender | Predisposing | Thyroid abnormalities | Intervention | ||
|---|---|---|---|---|---|---|---|---|
| Medical | Surgical | |||||||
| 1 | Svenungsson & Lindberg [ | 1 | 72 M | Steroid use | N/A | TMP-SMX (duration not specified) | None | |
| 2 | Walter and MacMonagle [ | 1 | 49F | None | MNG | Amoxicillin (duration not specified) | Thyroid lobectomy | |
| 3 | Fule and Saoji [ | 1 | N/A | N/A | N/A | N/A | N/A | |
| 4 | Nmadu [ | 2 | N/A | N/A | N/A | N/A | N/A | |
| 5 | Gudipati and Westblom [ | 1 | 79 M | N/A | N/A | Ceftriaxone × 2 weeks | I&D | |
| 6 | Igler, et al. [ | 1 | 70F | DM | MNG | TMP-SMX × 4 weeks | I&D | |
| 7 | Chiovato, et al. [ | 1 | 40F | None | MNG | Ceftriaxone × 10 days | Aspiration, I&D, and thyroid lobectomy | |
| 8 | Lalitha and John [ | 2 | N/A | N/A | None | None | None | |
| 9 | Lecuit, et al. [ | 1 | 48 M | HIV infection | None | Amoxicillin × 12 days | I&D | |
| 10 | Susković and Z Vucicević [ | 1 | 47F | DM | None | Antibiotics (not specified) | I&D | |
| 11 | Lala, et al. [ | 1 | 66 M | None | Thyroid nodule | Ciprofloxacin (duration not specified) | Subtotal thyroidectomy | |
| 12 | Jasmi, et al. [ | 1 | 62F | None | MNG | Amoxicillin-clavulinic acid × 3 days | Aspiration | |
| 13 | Duraker, et al. [ | 1 | 52 M | DM | None | Netilmicin + Clindamycin (duration not specified) | I&D | |
| Ofloxacin × 10 days | ||||||||
| 14 | Su and Huang [ | 1 | 79F | DM | MNG | Ampicillin (duration not specified) | Thyroid lobectomy | |
| Ceftriaxone × 17 days | ||||||||
| Ciprofloxacin (duration not specified) | ||||||||
| 15 | Dai, et al. [ | 1 | 82 M | CLL | MNG | Ceftriaxone (duration not specified) | I&D | |
| 16 | Sriburee [ | 1 | 55F | None | MNG | TMP-SMX × 2 weeks | Aspiration and I&D | |
| Cefazolin and metronidazole (duration not specified) | ||||||||
| 17 | Chen, et al. [ | 1 | 60F | Invasive thymoma | MNG | Ceftriaxone × 2 weeks | Thyroid lobectomy | |
| Oral antibiotics (duration not specified) | ||||||||
| 18 | Chou and Hsieh [ | 1 | 31F | None | MNG | Ampicillin/sulbactam | I&D | |
| Clindamycin and ceftriaxone (duration not specified) | ||||||||
| 19 | Krudop, et al. [ | 1 | 53F | None | MNG | Antibiotics (duration not specified) | I&D and thyroid lobectomy | |
| 20 | Wu, et al. [ | 1 | 74 M | Renal transplant on immunosuppressive therapy | None | Cefepime × 4 days, | Thyroid lobectomy | |
| Ceftriaxone × 28 days | ||||||||
| Lifelong antibiotics | ||||||||
| 21 | Ambroziak, et al. [ | 1 | 82 M | DM, and steroid use | None | Ceftriaxone × 2 weeks | Thyroid lobectomy | |
| Ampicillin × 3 weeks | ||||||||
| 22 | Kiss, et al. [ | 1 | 48F | HIV infection | N/A | Ceftriaxone × 2 weeks | I&D | |
| 23 | Kazi, et al. [ | 1 | 52 M | HIV infection | None | Lifelong TMP-SMX | Thyroid lobectomy | |
| 24 | Kuzu, et al. [ | 1 | 50F | DM | N/A | Metronidazole and ceftriaxone × 5 days | I&D | |
| Ciprofloxacin × 4 weeks | ||||||||
| 25 | Murali & Bhandary [ | 1 | 26F | None | MNG | Antibiotics × 1 week (duration not specified) | Thyroid lobectomy | |
| 26 | Hernik, et al. [ | 1 | 61F | DM | None | Clindamycin, ceftazidime × 1 week | I&D | |
| TMP-SMX × 1 week | ||||||||
| 27 | Vengathajalam, et al. [ | 1 | 58F | DM | MNG | Antibiotics (not specified) | Aspiration | |
| 28 | Quintana, et al. [ | 1 | N/A | None | N/A | Antibiotics (not specified) | None | |
F Female, M Male
N/A Not available or not mentioned in the article, MNG Multinodular goiter, DM Diabetes mellitus, HIV Human Immunodeficiency Virus, CLL Chronic lymphocytic leukemia, I&D Incision and drainage, TMP-SMX Trimethoprim/sulfamethoxazole